Mosaic expression of SLC35A2 pathogenetic variants impairs neuronal migration and dendritogenesis in the developing cortex
Human Molecular Genetics · 2025
DOI: 10.1093/hmg/ddaf156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Antonio Falace und 15 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto "Giannina Gaslini," via Gaslini 5, 16147 Genoa, Italy. Hauptthemen laut MEDLINE: Monosaccharide Transport Proteins, Cerebral Cortex, Epilepsy, Neurogenesis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Tuscany Region Call for Health 2018, Fondazione Cassa di Risparmio di Firenze (Human Brain Optical Mapping Project), 'Current Research Annual Funding' of the Italian Ministry of Health.
Abstract (Originalsprache)
Brain somatic variants in the SLC35A2 gene, encoding for a Golgi galactose transporter, represent the major cause of mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE). Clinical features associated with MOGHE include early-onset epileptic encephalopathy, drug-resistant focal epilepsy with developmental delay, and intellectual disability. Half of somatic SLC35A2 variants identified in MOGHE patients are predicted to encode full-length SLC35A2 protein or stable protein products. We investigated the pathophysiological basis of MOGHE by analyzing the functional consequences of SLC35A2 pathogenetic variants in vitro and in vivo models. We assessed how different SLC35A2 variants impact protein stability and expression in transfected cellular models. We used in utero electroporation in the rat brain to model mosaic expression of SLC35A2 pathogenetic variants in the cerebral cortex and assessed their effect on neurons migration and morphology. We found that SLC35A2 variants identified in MOGHE patients variably impact on SLC35A2 protein expression. In utero expression of a SLC35A2 missense (p.G282A) or frameshift (p.F280Tfs*10) variants resulted in neuronal heterotopia in the white matter and impaired dendritogenesis at postnatal stages, suggesting a cell autonomous role for SLC35A2 in neuronal development. These phenotypes were recapitulated by in utero silencing of rat Slc35a2 gene. We successfully developed an in vivo mosaic model for the characterization of SLC35A2 variants identified in MOGHE patients and demonstrated that the expression of single SLC35A2 variants triggers the pathophysiological cascade associated with SLC35A2 dysfunction in neurons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto "Giannina Gaslini," via Gaslini 5, 16147 Genoa, Italy.
- INMED, INSERM UMR1249, Aix Marseille University, Parc Scientifique de Luminy, 163 Av. de Luminy, 13009 Marseille, France.
- Department of Neuroscience and Human Genetics, Meyer Children's Hospital IRCCS, viale Pieraccini 24, 50139 Florence, Italy.
- Medical Genetics Unit, IRCCS Istituto "Giannina Gaslini," via Gaslini 5, 16147 Genoa, Italy.
- Department of Neuroscience, Pharmacology and Child Health, University of Florence, viale Pieraccini 6, 50139, Florence, Italy.
ORCID-Profile: Antonio Falace, Cristiana Pelorosso, Jean-Bernard Manent, Carmen Barba, Carlos Cardoso, Valerio Conti
Förderung
- Tuscany Region Call for Health 2018
- Fondazione Cassa di Risparmio di Firenze (Human Brain Optical Mapping Project)
- 'Current Research Annual Funding' of the Italian Ministry of Health
- Excellence Initiative of Aix-Marseille University/AMIDEX
- ‘Current Research Annual Funding’ of the Italian Ministry of Health
- Excellence Initiative of Aix–Marseille University/AMIDEX
Zitieren
APA
Falace, A., Corbières, L., Silvagnoli, L., Pelorosso, C., Tuccari di San Carlo, C., Buhler, E., Hoteit, Z., Bauer, S., Risso, B., Cesar, Q., Pallesi-Pocachard, E., Manent, J. B., Barba, C., Guerrini, R., Cardoso, C., & Conti, V. (2025). Mosaic expression of SLC35A2 pathogenetic variants impairs neuronal migration and dendritogenesis in the developing cortex. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf156
Vancouver
Falace A, Corbières L, Silvagnoli L, Pelorosso C, Tuccari di San Carlo C, Buhler E, et al. Mosaic expression of SLC35A2 pathogenetic variants impairs neuronal migration and dendritogenesis in the developing cortex. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf156
BibTeX
@article{Falace2025,
author = {Falace, Antonio and Corbières, Léa and Silvagnoli, Lucas and Pelorosso, Cristiana and Tuccari di San Carlo, Clara and Buhler, Emmanuelle and Hoteit, Zeinab and Bauer, Sylvian and Risso, Beatrice and Cesar, Quenol and Pallesi-Pocachard, Emilie and Manent, Jean-Bernard and Barba, Carmen and Guerrini, Renzo and Cardoso, Carlos and Conti, Valerio},
title = {Mosaic expression of SLC35A2 pathogenetic variants impairs neuronal migration and dendritogenesis in the developing cortex},
journal = {Human Molecular Genetics},
year = {2025},
doi = {10.1093/hmg/ddaf156}
}
EUVIMED